Gilead Sciences and Goldfinch Bio have entered a collaboration to discover, develop and commercialize a pipeline of therapeutics for diabetic kidney disease (DKD) and certain orphan kidney diseases.
Gilead and Goldfinch Bio have collaborated to discover, develop and commercialise a pipeline of innovative therapeutics for diabetic kidney disease (DKD) and certain orphan kidney diseases.